Comvet Competitors

PetSure. For a life with pets. PETS are at the heart of everything we do. We value and respect PEOPLE. We have PASSION for our business and give a damn about what we do and how we do it. We enable quality pet health care in Australia through the financial assistance that we offer, giving customers more choices about the protection and preservation of the lives of their pets.

The spacious, 3000sqm hospital features 14 modern consultation rooms, 3 state-of-the-art surgical theatres, a dedicated Emergency & Critical Care ward and advanced diagnostic equipment. At Greencross Vet Hospital we provide a wide range of veterinary services to our local community, and are here for all your pet care needs. Our hospital consists of a General Practice (GP) clinic, Emergency Service and Specialist Referral Hospital. Greencross also provides embedded clinical teaching and placement opportunities for University of Melbourne Doctor of Veterinary Medicine students. Our highly qualified and experienced teams are passionate about pets and are committed to providing the very best in veterinary care with exceptional client service.

Zoetis is the world’s leading animal health company. Our name comes from “Zoe,” the Greek word for life. The use of science to sustain life is at the foundation of everything we do. How can science create longer, more fulfilling lives for pets? Better life-saving treatments for veterinarians to use? More sustainable livelihoods for ranchers and livestock farmers, with safer food for the people they serve? We answer all of these questions through a mixture of innovation and compassion, leaning on cutting-edge technologies and deep-seated connections to our communities to create advancements in animal health vaccines, medicines, diagnostics and technologies. We ensure science is always at the center of our journey forward. Zoetis discovers, develops, manufactures and commercializes vaccines, medicines, diagnostics and other technologies for companion animals and livestock. A Fortune 500 company traded on the NYSE (ZTS), we generated $8.5 billion in revenue in 2023.